CTLA4 and lymphoma: The first study that documented CTLA-4 expression in tumor cells, published in 1997 in human lymphomas [64], suggested that CTLA-4 promotes tumor escape by inhibiting anti-tumor responses but not the proliferation of malignant lymphocytes [64].